Related Experiment Videos
The clinical spectrum of lipodermatosclerosis
R S Kirsner1, J B Pardes, W H Eaglstein
1Department of Dermatology and Cutaneous Surgery, University of Miami School of Medicine, FL 33136.
Journal of the American Academy of Dermatology
|April 1, 1993
Summary
Lipodermatosclerosis, a leg condition linked to venous insufficiency, presents with skin hardening and discoloration. Treatment involves compression therapy and the anabolic steroid stanozolol, which shows consistent improvement.
Area of Science:
- Dermatology
- Vascular Medicine
Background:
- Lipodermatosclerosis is characterized by leg skin induration and hyperpigmentation, frequently associated with venous insufficiency.
- It is also known as hypodermitis sclerodermiformis and may be identical to sclerosing panniculitis of the leg.
- Confusion exists regarding its nature, clinical course, and treatment.
Purpose of the Study:
- To clarify the nature, clinical course, and treatment of lipodermatosclerosis.
- To investigate the role of inflammation and fibrosis in the condition.
- To evaluate the efficacy of compression therapy and stanozolol.
Main Methods:
- Direct immunofluorescence studies on early and late lesions.
- Clinical observation of patients undergoing treatment.
- Review of existing literature and treatment protocols.
Main Results:
- Lipodermatosclerosis appears to have an acute inflammatory phase and a chronic fibrotic stage.
- Direct immunofluorescence reveals dermal pericapillary fibrin deposits without other immunoreactants.
- Compression therapy (stockings or bandages) is a primary treatment.
- The anabolic steroid stanozolol demonstrated rapid and consistent improvement.
Conclusions:
- Lipodermatosclerosis is a condition with distinct inflammatory and fibrotic phases.
- Diagnostic tools like direct immunofluorescence aid in understanding the pathology.
- Effective management includes compression therapy and the anabolic steroid stanozolol for rapid improvement.